Jason Dyck
Chief Tech/Sci/R&D Officer bei AUSTRALIS CAPITAL INC.
Vermögen: 109 545 $ am 31.03.2024
Profil
Jason R.
B.
Dyck is currently the Chairman at Canada Research Chairs Program.
He is also the Director-Cardiovascular Research Centre at the University of Alberta and the Director at Alberta Heart.
In addition, he holds the positions of Director & Chief Science Officer at Australis Capital, Inc. and Independent Director at Neural Therapeutics, Inc. Previously, Dr. Dyck served as the Co-Chairman-National Research Council at Diabetes Canada from 2017 to 2020.
He was also an Independent Director at Vertical Peak Holdings, Inc. from 2020 to 2022 and at Aurora Cannabis, Inc. from 2015 to 2020.
Furthermore, he held the position of Director at Binovi Technologies Corp.
in 2021.
Dr. Dyck obtained his doctorate degree from the University of Alberta in 1995.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AUSTRALIS CAPITAL, INC.
1,49% | 27.09.2022 | 4 376 785 ( 1,49% ) | 109 420 $ | 31.03.2024 |
| 25.09.2023 | 25 000 ( 0,01% ) | 125 $ | 31.03.2024 |
Aktive Positionen von Jason Dyck
| Unternehmen | Position | Beginn |
|---|---|---|
| AUSTRALIS CAPITAL INC. | Chief Tech/Sci/R&D Officer | 12.04.2021 |
| University of Alberta | Corporate Officer/Principal | 01.07.1999 |
| Alberta Heart | Director/Board Member | - |
Neural Therapeutics, Inc.
 Neural Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Neural Therapeutics, Inc. is an ethnobotanical drug-discovery company, which engages in the research and development of dietary supplements and psychedelic-based therapeutic medicines to treat mental ailments. It has established a supply chain in Peru to source certain specimen of mescaline-containing cacti, such as the San Pedro cactus. The company is headquartered in Toronto, Canada. | Director/Board Member | - |
| Canada Research Chairs Program | Chairman | - |
Ehemalige bekannte Positionen von Jason Dyck
| Unternehmen | Position | Ende |
|---|---|---|
| VERTICAL PEAK HOLDINGS INC. | Director/Board Member | 20.06.2022 |
| BINOVI TECHNOLOGIES CORP. | Director/Board Member | 21.12.2021 |
| AURORA CANNABIS INC. | Director/Board Member | 22.09.2020 |
Diabetes Canada
 Diabetes Canada Miscellaneous Commercial ServicesCommercial Services Diabetes Canada operates as a registered national charitable organization that is making the invisible epidemic of diabetes visible and urgent. The firm partners with Canadians to end diabetes through educational programs and support services, resources for health-care professionals, advocacy to governments, schools and workplaces and funding Canadian research. The company was founded by Charles Best in 1953 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 01.01.2020 |
| ░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Ausbildung von Jason Dyck
| University of Alberta | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| VERTICAL PEAK HOLDINGS INC. | Process Industries |
| AURORA CANNABIS INC. | Process Industries |
| BINOVI TECHNOLOGIES CORP. | Technology Services |
| CTT PHARMACEUTICAL HOLDINGS, INC. | Health Technology |
| AUSTRALIS CAPITAL INC. | Finance |
| Private Unternehmen | 4 |
|---|---|
Metabolic Modulators Research Ltd.
 Metabolic Modulators Research Ltd. Pharmaceuticals: MajorHealth Technology Metabolic Modulators Research Ltd. Operates as a biotechnology and pharmaceutical company. It specializes in scientific expertise, drug development, multilevel drug screen and therapeutic applications. The company was founded in 1997 and is headquartered in Edmonton, Canada. | Health Technology |
Diabetes Canada
Diabetes Canada Miscellaneous Commercial ServicesCommercial Services Diabetes Canada operates as a registered national charitable organization that is making the invisible epidemic of diabetes visible and urgent. The firm partners with Canadians to end diabetes through educational programs and support services, resources for health-care professionals, advocacy to governments, schools and workplaces and funding Canadian research. The company was founded by Charles Best in 1953 and is headquartered in Toronto, Canada. | Commercial Services |
| Canada Research Chairs Program | Government |
Neural Therapeutics, Inc.
Neural Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Neural Therapeutics, Inc. is an ethnobotanical drug-discovery company, which engages in the research and development of dietary supplements and psychedelic-based therapeutic medicines to treat mental ailments. It has established a supply chain in Peru to source certain specimen of mescaline-containing cacti, such as the San Pedro cactus. The company is headquartered in Toronto, Canada. | Health Technology |
